Costello Asset Management’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-385
Closed -$15.1K 183
2023
Q3
$15.1K Buy
385
+6
+2% +$239 0.01% 128
2023
Q2
$15.4K Buy
379
+6
+2% +$247 0.01% 129
2023
Q1
$15.6K Buy
373
+5
+1% +$210 0.02% 131
2022
Q4
$16K Buy
368
+6
+2% +$255 0.01% 134
2022
Q3
$14K Buy
362
+5
+1% +$213 0.01% 137
2022
Q2
$15K Buy
357
+5
+1% +$217 0.01% 146
2022
Q1
$16K Buy
+352
New +$15.6K 0.01% 157

Other funds holding BME

Costello Asset Management's BME Position: Q4 2023 in Review

Costello Asset Management sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 385 shares — an estimated $15.1K sold.

Costello Asset Management first reported a position in BME in Q1 2022 and held it in 7 quarters. The position peaked at $16K in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Costello Asset Management reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Costello Asset Management sold 385 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $15.1K.
  • Costello Asset Management first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 7 quarters.
  • Costello Asset Management's BlackRock Health Sciences Trust position peaked at $16K in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Costello Asset Management's 13F filing for Q4 2023, filed 29 Jan 2024.